{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:41:57Z","timestamp":1790764917209,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1053\/j.ajkd.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:54:54Z","timestamp":1541552094000},"page":"316-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Kidney Transplantation in C3 Glomerulopathy: A Case Series"],"prefix":"10.1053","volume":"73","author":[{"given":"Renu","family":"Regunathan-Shenk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupali S.","family":"Avasare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wooin","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro A.","family":"Canetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald B.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Bomback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1053\/j.ajkd.2018.09.002_bib1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nrneph.2012.213","article-title":"Pathogenesis of the C3 glomerulopathies and reclassification of MPGN","volume":"8","author":"Bomback","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2018.09.002_bib2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2018.09.002_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.molimm.2015.03.012","article-title":"The role of complement in C3 glomerulopathy","volume":"67","author":"Zipfel","year":"2015","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1053\/j.ajkd.2018.09.002_bib4","first-page":"450","article-title":"Toward a working definition of C3 glomerulopathy by immunofluorescence","volume":"85","author":"Hou","year":"2014","journal-title":"Kidney\u00a0Int"},{"issue":"4","key":"10.1053\/j.ajkd.2018.09.002_bib5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit\u00a0disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2018.09.002_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2215\/CJN.04700513","article-title":"C3 glomerulopathy: clinicopathologic features and predictors of outcome","volume":"9","author":"Medjeral-Thomas","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2018.09.002_bib7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/nep.12382","article-title":"Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical\u00a0features, and outcome in children","volume":"20","author":"Okuda","year":"2015","journal-title":"Nephrology"},{"issue":"2","key":"10.1053\/j.ajkd.2018.09.002_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000479012","article-title":"Immunosuppressive treatment in C3 glomerulopathy: is it really effective?","volume":"46","author":"Caliskan","year":"2017","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2018.09.002_bib9","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1681\/ASN.2013070715","article-title":"Clinical findings, pathology, and outcomes of C3GN after kidney transplantation","volume":"25","author":"Zand","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2018.09.002_bib10","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/ndt\/14.7.1723","article-title":"Renal transplantation in patients with dense deposit disease: morphological characteristics of recurrent disease and clinical outcome","volume":"14","author":"Andresdottir","year":"1999","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2018.09.002_bib11","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1681\/ASN.2005020175","article-title":"Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: the North American Pediatric Renal Transplant Cooperative Study experience","volume":"16","author":"Braun","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2018.09.002_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A\u00a0more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1053\/j.ajkd.2018.09.002_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2215\/CJN.07900811","article-title":"Causes of alternative pathway dysregulation in dense deposit disease","volume":"7","author":"Zhang","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2018.09.002_bib14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2012.212","article-title":"C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up","volume":"82","author":"Sethi","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2018.09.002_bib15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ki.2015.195","article-title":"Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits","volume":"88","author":"Larsen","year":"2015","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2018.09.002_bib16","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s00467-013-2503-y","article-title":"Eculizumab and recurrent C3 glomerulonephritis","volume":"28","author":"Gurkan","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2018.09.002_bib17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2215\/CJN.12901211","article-title":"Eculizumab for dense deposit disease and C3 glomerulonephritis","volume":"7","author":"Bomback","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2018.09.002_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.kint.2017.10.022","article-title":"C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy","volume":"93","author":"Bomback","year":"2018","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.ajkd.2018.09.002_bib19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ki.2010.1","article-title":"Recurrent membranoproliferative glomerulonephritis after kidney transplantation","volume":"77","author":"Lorenz","year":"2010","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2018.09.002_bib20","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/TP.0b013e318218e94e","article-title":"Membranoproliferative glomerulonephritis type I in renal transplantation patients: a single-center study of a cohort of 68 renal transplants followed up for 11 years","volume":"91","author":"Moroni","year":"2011","journal-title":"Transplantation"},{"issue":"6","key":"10.1053\/j.ajkd.2018.09.002_bib21","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/TP.0000000000000459","article-title":"Recurrent membranoproliferative\u00a0glomerulonephritis type I after kidney transplantation: a 17-year single-center experience","volume":"99","author":"Green","year":"2015","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2018.09.002_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12882-015-0219-x","article-title":"Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification","volume":"17","author":"Alasfar","year":"2016","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2018.09.002_bib23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/MNH.0000000000000358","article-title":"Recurrent glomerular disease after\u00a0kidney trasnplantation","volume":"26","author":"Blosser","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"10.1053\/j.ajkd.2018.09.002_bib24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.kint.2016.08.030","article-title":"Recent advances in our understanding of recurrent primary glomerulonphritis after kidney transplantation","volume":"91","author":"Cosio","year":"2017","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2018.09.002_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMoa013036","article-title":"Risk of renal allograft loss from recurrent glomerulonephritis","volume":"347","author":"Briganti","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2018.09.002_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2017.11.019","article-title":"Patterns of clinical response to eculizumab in patients with C3 glomerulopathy","volume":"72","author":"Le Quintrec","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2018.09.002_bib27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1053\/j.ajkd.2013.02.370","article-title":"C3 glomerulonephritis associated with monoclonal gammopathy: a case series","volume":"62","author":"Zand","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2018.09.002_bib28","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1182\/blood-2016-08-737163","article-title":"Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy","volume":"129","author":"Chauvet","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.ajkd.2018.09.002_bib29","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/ckj\/sfw090","article-title":"C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome","volume":"9","author":"Lloyd","year":"2016","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1053\/j.ajkd.2018.09.002_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","article-title":"Thrombotic microangiopathy associated with monoclonal gammopathy","volume":"91","author":"Ravindran","year":"2017","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2018.09.002_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.ajkd.2007.11.032","article-title":"Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits","volume":"51","author":"Boyer","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2018.09.002_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5414\/CN107945","article-title":"Remission of C3 glomerulopathy with rituximab as only immunosuppressive therapy","volume":"83","author":"Giaime","year":"2015","journal-title":"Clin Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2018.09.002_bib33","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00467-017-3619-2","article-title":"C3 glomerulopathy and eculizumab: a report on four paediatric cases","volume":"32","author":"Lebreton","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2018.09.002_bib34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.ajkd.2014.09.025","article-title":"Eculizumab for treatment of rapidly progressive C3 glomerulopathy","volume":"65","author":"Le Quintrec","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ajkd.2018.09.002_bib35","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMc1111953","article-title":"Eculizumab for the treatment of\u00a0dense-deposit disease","volume":"366","author":"Vivarelli","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1053\/j.ajkd.2018.09.002_bib36","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2215\/CJN.01360215","article-title":"Eculizumab in pediatric dense deposit disease","volume":"10","author":"Oosterveld","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2018.09.002_bib37","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMc1112273","article-title":"Eculizumab in a patient with dense-deposit disease","volume":"366","author":"Daina","year":"2012","journal-title":"N\u00a0Engl J Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618309788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618309788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:18:20Z","timestamp":1759461500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638618309788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0272638618309788"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.09.002","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney Transplantation in C3 Glomerulopathy: A Case Series","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}